• Scaling Cell and Gene Therapy Manufacturing

    Scaling Cell and Gene Therapy Manufacturing

    Cellipont Bioservices evaluated the Xiogenix ARES™ X20+ across small-scale vial and large-scale bag fill-finish workflows, examining fill performance, process efficiency, cell quality, and scalability. See what they found.
  • Explore the Full Paper and Automated Fill-Finish Performance

  • Format: (000) 000-0000.
  • Interested in what these findings could mean for your process? Connect with the Xiogenix team to discuss your formulation and fill-finish workflow.

    Inquiries can be directed to kate.pavletich@xiogenix.com.

     

     

     

  • Should be Empty: